Development of a Pan-Botulinum Neurotoxin Medical Countermeasure
Award Notice Posted
- Solicitation number
- BARDA2020
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Awarded
- to Mapp Biopharmaceutical, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75A50120C00198 Federal contract award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- San Diego CA 92121 USA
Notice details come from SAM.gov. Updated .
About this opportunity
MAPP Biopharmaceutical, Inc. was awarded a contract valued at $14,275,638 by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response on September 29, 2020. The contract is for the development of a pan-botulinum neurotoxin medical countermeasure, under which the contractor will initiate antibody discovery activities focused on generating novel, broadly neutralizing Botulinum neurotoxin antibodies over an unspecified period of time.
Notice text
The Contractor will initiate antibody discovery activities focused on the generation of novel, broadly neutralizing Botulinum neurotoxin (BoNT) antibodies. This contract is not fixed-price due to the complexities of unknown potential results associated with this type of research and development.
Awarded contract 75A50120C00198 to MAPP BIOPHARMACEUTICAL, INC. for 14275638.00 on 2020-09-29.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity